For: | Shimoda M, Kubota K. Multi-disciplinary treatment for cholangiocellular carcinoma. World J Gastroenterol 2007; 13(10): 1500-1504 [PMID: 17461440 DOI: 10.3748/wjg.v13.i10.1500] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i10/1500.htm |
Number | Citing Articles |
1 |
Jong Ryul Eun, Byung Ik Jang, Jun Young Lee, Kyung Ok Kim, Si Hyung Lee, Tae Nyeun Kim, Heon Ju Lee. Clinical Characteristics of Intrahepatic Cholangiocarcinoma and Prognostic Factors in Patients Who Received Non-surgical Treatment. The Korean Journal of Gastroenterology 2009; 54(4): 227 doi: 10.4166/kjg.2009.54.4.227
|
2 |
Murad Aljiffry, Mark J Walsh, Michele Molinari. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World Journal of Gastroenterology 2009; 15(34): 4240-4262 doi: 10.3748/wjg.15.4240
|
3 |
Alphonse E Sirica. Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma. World Journal of Gastroenterology 2008; 14(46): 7033-7058 doi: 10.3748/wjg.14.7033
|
4 |
SEN-LIN MA, AI-JUN LI, ZHAO-YANG HU, FU-SHENG SHANG, MENG-CHAO WU. Co-expression of the carbamoyl-phosphate synthase 1 gene and its long non-coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma. Molecular Medicine Reports 2015; 12(6): 7915 doi: 10.3892/mmr.2015.4435
|
5 |
|
6 |
Mai-Lan Ho, Christine M. Peterson, Vamsidhar R. Narra. Abdominal Imaging. 2011; : 890 doi: 10.1016/B978-1-4160-5449-8.00086-X
|
7 |
QI WANG, HUIHUAN TANG, SHANSHAN YIN, CHAO DONG. Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9. Oncology Reports 2013; 29(5): 2046 doi: 10.3892/or.2013.2304
|
8 |
HAIXIA YANG, JIUPENG ZHOU, XIN WEI, FAN WANG, HUADONG ZHAO, ENXIAO LI. Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor. Molecular and Clinical Oncology 2014; 2(6): 1069 doi: 10.3892/mco.2014.377
|
9 |
Saini Wang, Anil Kumar Yadav, Jin-Yi Han, Keun Soo Ahn, Byeong-Churl Jang. Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α. International Journal of Molecular Sciences 2022; 23(11): 6353 doi: 10.3390/ijms23116353
|
10 |
Chunxia Wang, Thorsten Maass, Markus Krupp, Florian Thieringer, Susanne Strand, Marcus A. Wörns, Ana-Paula Barreiros, Peter R. Galle, Andreas Teufel. A systems biology perspective on cholangiocellular carcinoma development: Focus on MAPK-signaling and the extracellular environment. Journal of Hepatology 2009; 50(6): 1122 doi: 10.1016/j.jhep.2009.01.024
|
11 |
Carsten Kamphues, D. Seehofer, R. M. Eisele, T. Denecke, J. Pratschke, U. P. Neumann, P. Neuhaus. Recurrent intrahepatic cholangiocarcinoma: single‐center experience using repeated hepatectomy and radiofrequency ablation. Journal of Hepato-Biliary-Pancreatic Sciences 2010; 17(4): 509 doi: 10.1007/s00534-009-0256-6
|
12 |
Manoj K. Singh, Marcelo E. Facciuto. Current Management of Cholangiocarcinoma. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 2012; 79(2): 232 doi: 10.1002/msj.21298
|
13 |
Seok Ling Ong, Giuseppe Garcea, Kevin Mulcahy, Yvonne Rees, David P. Berry, Ashley R. Dennison. The role of positron emission tomography (PET) in detecting local recurrence cholangiocarcinoma. European Journal of Radiology Extra 2008; 68(1): 21 doi: 10.1016/j.ejrex.2008.05.027
|
14 |
C. Hillert, X. Rogiers. Hepatobiliäre und Pankreastumoren. 2010; : 204 doi: 10.1007/978-3-642-04935-4_15
|
15 |
Jie-Ying Xu, Zhen-Long Ye, Du-Qing Jiang, Jiang-Chuan He, Yong-Mei Ding, Lin-Fang Li, Sai-Qun Lv, Ying Wang, Hua-Jun Jin, Qi-Jun Qian. Mesothelin-targeting chimeric antigen receptor–modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma. Tumor Biology 2017; 39(4): 101042831769594 doi: 10.1177/1010428317695949
|
16 |
Laura Elise Horvath, Edgardo Yordan, Deepak Malhotra, Ileana Leyva, Katy Bortel, Denise Schalk, Patricia Mellinger, Marianne Huml, Christy Kesslering, Jeffrey Huml. Multidisciplinary Care in the Oncology Setting: Historical Perspective and Data From Lung and Gynecology Multidisciplinary Clinics. Journal of Oncology Practice 2010; 6(6): e21 doi: 10.1200/JOP.2010.000073
|
17 |
Xue Cai, Weigang Ge, Xiao Yi, Rui Sun, Jiang Zhu, Cong Lu, Ping Sun, Tiansheng Zhu, Guan Ruan, Chunhui Yuan, Shuang Liang, Mengge Lyu, Shiang Huang, Yi Zhu, Tiannan Guo. PulseDIA: Data-Independent Acquisition Mass Spectrometry Using Multi-Injection Pulsed Gas-Phase Fractionation. Journal of Proteome Research 2021; 20(1): 279 doi: 10.1021/acs.jproteome.0c00381
|
18 |
Mai-Lan Ho, Christine M. Peterson, Vamsidhar R. Narra. Abdominal Imaging. 2011; : 882 doi: 10.1016/B978-1-4160-5449-8.00085-8
|
19 |
Gory Ballester-Ortiz, Leonardo Marcal, Chitra Viswanathan, Janio Szklaruk. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 167 doi: 10.1007/978-3-642-40558-7_12
|
20 |
Thomas J. Vogl, Nagy N.N. Naguib, Nour‐Eldin A. Nour‐Eldin, Wolf O. Bechstein, Stefan Zeuzem, Jörg Trojan, Tatjana Gruber‐Rouh. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success. International Journal of Cancer 2012; 131(3): 733 doi: 10.1002/ijc.26407
|
21 |
Kyoji Ito, Yoshihiro Sakamoto, Hiroyuki Isayama, Yosuke Nakai, Takeyuki Watadani, Mariko Tanaka, Tetsuo Ushiku, Nobuhisa Akamatsu, Junichi Kaneko, Junichi Arita, Kiyoshi Hasegawa, Norihiro Kokudo. The Impact of MDCT and Endoscopic Transpapillary Mapping Biopsy to Predict Longitudinal Spread of Extrahepatic Cholangiocarcinoma. Journal of Gastrointestinal Surgery 2018; 22(9): 1528 doi: 10.1007/s11605-018-3793-y
|
22 |
Ramesh K. Ramanathan, Chandra P. Belani, Deepti A. Singh, Michael Tanaka, Heinz-Josef Lenz, Yun Yen, Hedy L. Kindler, Syma Iqbal, Jeff Longmate, Philip C. Mack, Georg Lurje, Regina Gandour-Edwards, Janet Dancey, David R. Gandara. A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer. Cancer Chemotherapy and Pharmacology 2009; 64(4): 777 doi: 10.1007/s00280-009-0927-7
|
23 |
Rocio I. R. Macias. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives. ISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/828074
|
24 |
Junwen Hu, Rongfa Yuan, Changwen Huang, Jianghua Shao, Shubing Zou, Kai Wang. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0974-6
|
25 |
Mina Komuta, Bart Spee, Sara Vander Borght, Rita De Vos, Chris Verslype, Raymond Aerts, Hirohisa Yano, Tetsuya Suzuki, Masanori Matsuda, Hideki Fujii, Valeer J. Desmet, Masamichi Kojiro, Tania Roskams. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 2008; 47(5): 1544 doi: 10.1002/hep.22238
|
26 |
Dakeun Lee, In-Gu Do, Kyusam Choi, Chang Ohk Sung, Kee-Taek Jang, Dongwook Choi, Jin Seok Heo, Seoung Ho Choi, Jongmin Kim, Jin Young Park, Hyung Jin Cha, Jae-Won Joh, Kwan Yong Choi, Dae Shick Kim. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas. Modern Pathology 2012; 25(1): 131 doi: 10.1038/modpathol.2011.133
|
27 |
Gun Min Kim, Hei-Cheul Jeung, Dokyung Kim, Joo Hoon Kim, Sang Hyun Yoon, Eun Suk Jung, Sang Joon Shin. A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy. Cancer Research and Treatment 2010; 42(4): 235 doi: 10.4143/crt.2010.42.4.235
|
28 |
Meng-Meng Qu, Yuan-Hui Zhu, Yi-Xiang Li, Zhi-Fan Li, Jin-Kui Li, Yong-Sheng Xu, Manishkumar Shrestha, Jun-Qiang Lei. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Medicine 2021; 100(46): e27349 doi: 10.1097/MD.0000000000027349
|
29 |
Sung Ryol Lee, Hyung Ook Kim, Jun Ho Shin. The Strategy of Treatment for Mid to Distal Cholangiocarcinoma after Surgical Resection. The American Surgeon™ 2018; 84(6): 820 doi: 10.1177/000313481808400625
|